Samples Of Antibiotics Found Fake In Testing

Ghaziabad : Samples of three antibiotics have failed in the quality tests. These include Zifi 200, Augmentin 625 and Clavam 625 medicines sold in the name of renowned companies. The officials of the FSDA will now take action by finding out the racket behind these fake medicines. Action will also be taken against the medical store operators.

Drug Inspector Ashutosh Mishra said that these samples were taken from Rana Medicos in Dasna in November. They were sent for testing. Recently their test report has been received in which the samples of all the three medicines were found to have failed in quality tests. The active ingredients which should have been there in the medicines were not found. It shows fake medicines were being sold in the market in the name of these companies.

Drug Inspector Ashutosh Mishra told that there is a passcode on the medicine named Zifi 200 mg, through which it was known that it is fake. On the basis of this, a report was filed against the medical store Mohammad Ismail in November itself and his arrest was made. The court sent him to jail. Now after the test report arrives, another case will be registered, in which the punishment can be up to life imprisonment.

The drug named Zifi is manufactured by M/s FDC Ltd. and its plant is located in Baddi Solan, Himachal Pradesh. The drug named Clavam is manufactured by a Sikkim-based company named Alkem Health Science and Augmentin drug is marketed by a company named Glaxo. FSDA officials say that the names of well-known companies were written on the packets of these fake medicines like real medicines. So that the buyers get into the trap.

  • Related Posts

    • Pharma
    • July 13, 2024
    • 103 views
    Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

    Hyderabad: Drugs Control Administration officials seized ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg), during the raids carried out on 11th and 12th July, 2024, at a medical shop located in…

    • Pharma
    • July 13, 2024
    • 82 views
    Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

    Kolkata: The Drug Price Control Order (DPCO) 2013, India’s key drug regulation aimed at making essential medicines more affordable, has inadvertently led to a decline in the availability of these…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

    Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

    Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

    Drug Price Regulation Leads To Decline In Availability Of Essential Medicines, Study Finds

    EMA Warns Of Anaphylactic Reactions To MS Drug

    EMA Warns Of Anaphylactic Reactions To MS Drug

    14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

    14 Barred Patanjali Products Sold Across Counter At Dedicated Stores

    Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

    Mumbai: FDA Conducts Raids At Three Different Locations In Vasai, Seized Ayurvedic Drugs Worth Rs 1.41 Crore

    Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines

    Telangana DCA Raids 2 Places, Seizes Illegally Stocked And Overpriced Medicines